Community-acquired MRSA infection: An emerging trend

British Columbia Medical Journal

Volumn 48, Issue 3, 2006, Pages 116-120

  Cimolai, Nevio ^a,b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33645964304     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Weber JT. Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005;41(suppl 4):S269-S272.
2. Cimolai N. Staphylococcus aureus outbreaks among newborns: New frontiers in an old dilemma. Amer J Perinatol 2003;20:125-136.
3. BC Biomedical Laboratories, Surrey, BC. Empiric therapy antibiogram.www.bcbio.com/hcpros/references/treatment_guidelines.htm (accessed 15 December 2005).
4. Purcell K, Fergie J. Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: A 14-year study at Driscoll Children's Hospital. Arch Pediatr Adolesc Med 2005;159:980-985.
5. Stevenson KB, Searle K, Stoddard GJ, et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in rural communities, western United States. Emerg Infect Dis 2005;11:895-903.
6. Moran GJ, Amii RN, Abrahamian FM, et al. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerg Infect Dis 2005;11:928-930.
7. Rihn JA, Michaels MG, Harner CD. Community-acquired methicillin-resistant Staphylococcus aureus: An emerging problem in the athletic population. Am J Sports Med 2005;33:1924-1929.
8. Cimolai N. Are all MRSA made equal? Can J Microbiol 2002;48:560-566.
9. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444.
10. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005;352:1445-1453.
11. Creech CB, Kernodle DS, Alsentzer A, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005;24:617-621.
12. Mulvey MR, MacDougall L, Cholin B, et al. Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis 2005;11:844-850.
13. Ellis MW, Lewis JS. Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis 2005;18:496-501.
14. Eron LJ, Lipsky BA, Low DE, et al. Managing skin and soft tissue infections: Expert panel recommendations on key decision points. J Antimicrob Chemother 2003:52(suppl 1):i3-i17.
15. Fung HB, Chang JY, Kuczynski S. A practical guide to the treatment of complicated skin and soft tissue infections. Drugs 2003;63:1459-1480.
16. Eron J. Infections of skin and soft tissue: Outcomes of a classification scheme. Clin Infect Dis 2000;31:287(A432).
17. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99-104.